Diagnostic endoscopic procedures on the upper gastrointestinal tract

Series
Gastrointestinal
Status
Published
Date
Number of report
055

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for diagnostic endoscopic procedures on the upper gastrointestinal tract for benign and malignant diseases in outpatient settings.

Sample pages are provided for an older version of the report. Before delivery to the client, the report is updated to the current state (e.g., 2022 coding, tariffs, and policy considerations). 

The following procedures will be considered:

  • Esophagoscopy
  • Gastroscopy
  • Duodenoscopy

The report will consider both stand-alone diagnostic procedures and in combination with biopsy of lesions.

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of endoscope equipment for the upper gastrointestinal tract include:

  • Alltion (Fiber-GIS)
  • Aohua Ednoscopy (FHD-GT, VGT, VME)
  • Cogentix Medical (PrimeSight)
  • Cook Medical (Shooter Saeed, Shooter Universal Saeed)
  • Endomed Systems (Duo, Combo-2)
  • Fujifilm Holdings Corporation (Eluxeo EG, ED)
  • Huger Endoscopy System (GVE)
  • Interscope (EndoRotor)
  • IntroMedic (E.G. Scan)
  • KARL STORZ GmbH & Co. KG (Silver Scope, Tele Pack X)
  • Olympus (EVIS EXERA-Gif)
  • Pentax medical (MagniView EG, Transnasal EG, G-EYE)
  • SonoScape (EG-330 series)
  • Stryker Corporation (1588 AIM)

Table of content is not available at the moment. Report is still ongoing.

04

Jul 2022

On June 15, 2022, the National Institute for Health and Care Excellence (NICE) announced a new program called Early Value Assessment for Medtech. The program will offer a rapid assessment of digital products, devices, and diagnostics for clinical effectiveness and value for money where the evidence base is still emerging to inform NHS commissioners. The two pilot assessments for health apps will begin in June 2022 and are expected to be published in October 2022. Further topics are expected in mental health, early cancer diagnosis, and cardiovascular disease.

Read more

10

Jun 2022

On May 31, 2022, the French National Authority for Health (HAS) published the final positive opinion on the coverage of the endoscopic gastroplasty with the ENDOMINA triangulation platform under the Innovation package (Forfait innovation).

Read more

26

Apr 2022

The revised EBM (German Uniform Evaluation Standard) catalog came into force on April 1, 2022. The most significant changes concern the introduction of new additional flat rates for the observation and care of patients who are given certain medications, adjustment of EBM reproductive medicine definitions, and inclusion of several new codes for PET and PET/CT.

Read more

20

Apr 2022

In mid-March 2022, the Danish Health Data Agency (Sundhedsstyrelsen) published an update of the Health Care Classification System (Sundheds-væsenets Klassifikations System, SKS). The most significant changes include: ten new diagnosis codes, two procedure codes, and 143 additional codes (Tillægskoder) were added. The newly added procedure codes concern gastrointestinal and peripheral vascular procedures.

Read more

18

Feb 2022

Dutch Organization for Health Research and Development, ZonMw awarded eight projects under the "Healthcare Evaluation and Appropriate Use" program, including two projects for geriatric care, two projects for cancer, per one project for cardiovascular, neurovascular, and dermatology care.

Read more
(we accept only company emails)